Research graph
References from Risk of severe COVID-19 outcomes in individuals with prior cancer diagnosis – A nationwide Swedish register-based cohort study. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
10.1016/s0140-6736(20)30183-5 · 2020 · External reference
characteristics of persons who died with COVID-19 - United States, February 12-May 18, 2020
10.15585/mmwr.mm6928e1 · 2020 · External reference
Clinical outcomes of COVID-19 in patients with chronic diseases
2023 · External reference
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review
10.1093/oncolo/oyaf074 · 2025 · External reference
A systematic review and meta-analysis of cancer patients affected by a novel coronavirus
2020 · External reference
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
10.1136/bmjopen-2020-044661 · 2022 · External reference
Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients
10.7554/elife.74634 · 2022 · External reference
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
10.1007/s00432-022-04191-y · 2023 · External reference
COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
10.1016/j.jinf.2021.01.022 · 2021 · External reference
Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study
10.1007/s10654-021-00732-w · 2021 · External reference
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
10.1016/s1470-2045(20)30096-6 · 2020 · External reference
Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak
10.1158/2159-8290.cd-20-0422 · 2020 · External reference
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
10.1016/s1470-2045(20)30309-0 · 2020 · External reference
Older adults with cancer and their caregivers - current landscape and future directions for clinical care
10.1038/s41571-020-0421-z · 2020 · External reference
Clinical outcomes in cancer patients with COVID-19 in Sweden
10.1080/0284186x.2021.1973679 · 2021 · External reference
Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities
10.1080/0284186x.2021.1934536 · 2021 · External reference
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
10.1080/0284186x.2021.1958005 · 2021 · External reference
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era
10.1182/bloodadvances.2024015260 · 2025 · External reference
COVID-19 infection and severity among childhood cancer survivors in Denmark and Sweden: a register-based cohort study with matched population and sibling comparisons
2025 · External reference
Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis
10.1093/jnci/djaa168 · 2021 · External reference
Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data
10.1200/go.20.00225 · 2020 · External reference
Clinical characteristics and outcomes of cancer patients with COVID-19
10.1002/jmv.25972 · 2020 · External reference
Clinical characteristics and outcomes in patients with COVID-19 and cancer: a systematic review and meta-analysis
10.1016/j.clon.2020.11.006 · 2021 · External reference
Mortality and hospitalization risks in patients with cancer and the SARS-CoV-2 omicron variant
10.1001/jamaoncol.2023.5042 · 2024 · External reference
Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study
10.1136/bmj-2022-072976 · 2023 · External reference
COVID-19 outcomes by cancer status, site, Treatment, and vaccination
2023 · External reference
Brief report: impact of anti-cancer treatments on outcomes of COVID-19 in patients with thoracic cancers: a CCC19 registry analysis
10.1016/j.cllc.2024.04.003 · 2024 · External reference
Swedish Covid-19 investigation for future insights - a population epidemiology approach using register linkage (SCIFI-PEARL)
10.2147/clep.s312742 · 2021 · External reference
Unresolved reference
External reference
Occupational role and COVID-19 among foreign-born healthcare workers in Sweden: a registry-based study
10.1093/eurpub/ckad016 · 2023 · External reference
Unresolved reference
External reference
Social distancing to avoid SARS-CoV-2 infection in cancer and noncancer patients
10.1097/pts.0000000000001058 · 2022 · External reference
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients
10.1186/s12879-021-06536-3 · 2021 · External reference
COVID-19 and cancer consortium, clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
10.1016/s0140-6736(20)31187-9 · 2020 · External reference
Severity of COVID-19 in patients with lung cancer: evidence and challenges
10.1136/jitc-2020-002266 · 2021 · External reference
Distribution of metastatic sites in patients with prostate cancer: a population-based analysis
10.1002/pros.22742 · 2014 · External reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer
10.1016/j.eururo.2024.04.010 · 2024 · External reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. part i: screening, diagnosis, and local treatment with curative intent
10.1016/j.eururo.2024.03.027 · 2024 · External reference
Comparison of relative survival and cause-specific survival in men with prostate cancer according to age and risk category: a nationwide, population-based study
10.1093/aje/kwab146 · 2021 · External reference
Mortality and hospitalization risks in patients with cancer and the SARS-CoV-2 omicron variant
10.1001/jamaoncol.2023.5042 · ExternalCitation · doi-reference
Clinical characteristics and outcomes of cancer patients with COVID-19
10.1002/jmv.25972 · ExternalCitation · doi-reference
Distribution of metastatic sites in patients with prostate cancer: a population-based analysis
10.1002/pros.22742 · ExternalCitation · doi-reference
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients
10.1007/s00432-022-04191-y · ExternalCitation · doi-reference
Risk factors for COVID-19 diagnosis, hospitalization, and subsequent all-cause mortality in Sweden: a nationwide study
10.1007/s10654-021-00732-w · ExternalCitation · doi-reference
Brief report: impact of anti-cancer treatments on outcomes of COVID-19 in patients with thoracic cancers: a CCC19 registry analysis
10.1016/j.cllc.2024.04.003 · ExternalCitation · doi-reference
Clinical characteristics and outcomes in patients with COVID-19 and cancer: a systematic review and meta-analysis
10.1016/j.clon.2020.11.006 · ExternalCitation · doi-reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. part i: screening, diagnosis, and local treatment with curative intent
10.1016/j.eururo.2024.03.027 · ExternalCitation · doi-reference
EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II-2024 update: treatment of relapsing and metastatic prostate cancer
10.1016/j.eururo.2024.04.010 · ExternalCitation · doi-reference
COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients
10.1016/j.jinf.2021.01.022 · ExternalCitation · doi-reference
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
10.1016/s0140-6736(20)30183-5 · ExternalCitation · doi-reference
COVID-19 and cancer consortium, clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
10.1016/s0140-6736(20)31187-9 · ExternalCitation · doi-reference
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
10.1016/s1470-2045(20)30096-6 · ExternalCitation · doi-reference
Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
10.1016/s1470-2045(20)30309-0 · ExternalCitation · doi-reference
Older adults with cancer and their caregivers - current landscape and future directions for clinical care
10.1038/s41571-020-0421-z · ExternalCitation · doi-reference
Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities
10.1080/0284186x.2021.1934536 · ExternalCitation · doi-reference
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study
10.1080/0284186x.2021.1958005 · ExternalCitation · doi-reference
Clinical outcomes in cancer patients with COVID-19 in Sweden
10.1080/0284186x.2021.1973679 · ExternalCitation · doi-reference
Comparison of relative survival and cause-specific survival in men with prostate cancer according to age and risk category: a nationwide, population-based study
10.1093/aje/kwab146 · ExternalCitation · doi-reference
Occupational role and COVID-19 among foreign-born healthcare workers in Sweden: a registry-based study
10.1093/eurpub/ckad016 · ExternalCitation · doi-reference
Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis
10.1093/jnci/djaa168 · ExternalCitation · doi-reference
COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review
10.1093/oncolo/oyaf074 · ExternalCitation · doi-reference
Social distancing to avoid SARS-CoV-2 infection in cancer and noncancer patients
10.1097/pts.0000000000001058 · ExternalCitation · doi-reference
Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study
10.1136/bmj-2022-072976 · ExternalCitation · doi-reference
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis
10.1136/bmjopen-2020-044661 · ExternalCitation · doi-reference
Severity of COVID-19 in patients with lung cancer: evidence and challenges
10.1136/jitc-2020-002266 · ExternalCitation · doi-reference
Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak
10.1158/2159-8290.cd-20-0422 · ExternalCitation · doi-reference
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era
10.1182/bloodadvances.2024015260 · ExternalCitation · doi-reference
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients
10.1186/s12879-021-06536-3 · ExternalCitation · doi-reference
Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data
10.1200/go.20.00225 · ExternalCitation · doi-reference
characteristics of persons who died with COVID-19 - United States, February 12-May 18, 2020
10.15585/mmwr.mm6928e1 · ExternalCitation · doi-reference
Swedish Covid-19 investigation for future insights - a population epidemiology approach using register linkage (SCIFI-PEARL)
10.2147/clep.s312742 · ExternalCitation · doi-reference
Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients
10.7554/elife.74634 · ExternalCitation · doi-reference
